We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fission and Fusion Among the Mitochondria

By Biotechdaily staff writers
Posted on 27 Oct 2004
Two recently published studies describe advances in understanding how mitochondria, double-membrane bound intracellular organelles, divide and reform during the process of cell division.

Investigators at Johns Hopkins University (Baltimore, MD, USA), the California Institute of Technology (Palo Alto, USA), and the University of California, Davis (USA) used advanced optical and electronic microscope techniques to study mitochondria that had been isolated from their host cells.

They found that mitochondrial fission and subsequent fusion required mitofusin, an integral mitochondrial membrane protein. More...
A seven amino acid repeat unit formed a coiled structure that spanned the membrane and allowed binding on either side. Mitochondrial outer and inner membrane fusion events were separable and mechanistically distinct, but both required energy supplied by guanosine 5'-triphosphate hydrolysis. These findings were reported in the August 6 and September 17, 2004, issues of Science.

"We observed two distinct stages, with the first involving outer membrane fusion yielding an intermediate structure of two conjoined mitochondria, followed by the subsequent fusion of the inner membranes giving rise to a single mitochondrion,” explained contributing author Dr. J. Michael McCaffery, director of the integrated imaging center at Johns Hopkins University. "Understanding the discrete molecular events that underlie dynamic mitochondrial behavior has the potential to reveal keen insights into the basic and essential cell-mitochondria relationship, leading to increased understanding of the aging process; and potential treatments and perhaps cures of those age-related scourges of Parkinson's and Alzheimer's.”

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.